This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Universal Health's (UHS) Q3 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q3 earnings are likely to have suffered elevated costs, partly offset by better patient volumes.
Centene (CNC) Gears Up for Q3 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) third-quarter results are likely to reflect better revenues and membership growth.
Why Acadia Healthcare (ACHC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Acadia Healthcare (ACHC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Acadia Healthcare (ACHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings results reflect better revenues and higher patient volumes.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter results reflect higher revenues and solid contribution from its segments.
What's in Store for HCA Healthcare's (HCA) Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 results are likely to reflect better revenues owing to higher patient volumes.
Mednax (MD) Invests in Brave Care to Boost Pediatric Business
by Zacks Equity Research
Mednax (MD) and Brave Care form a relationship to provide enhanced pediatric care and pursue its pipeline of pediatric clinics' plan.
Ensign Group (ENSG) Acquires to Expand in Texas & Idaho
by Zacks Equity Research
Ensign Group (ENSG) establishes dominance in the Texas and Idaho markets with further buyouts.
Cigna's (CI) 2022 Expansion Plans to Boost MA Customer Base
by Zacks Equity Research
Cigna (CI) unveils enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties and states to offer enhanced health outcomes.
UnitedHealth (UNH) Unit to Offer Better Pharmacy Care in Arizona
by Zacks Equity Research
Genoa, which comes under UnitedHealth Group's (UNH) subsidiary Optum, opens a pharmacy in one of Arizona's clinics for offering enhanced pharmacy care for behavioral health patients.
HCA Healthcare (HCA) Up 109.5% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) cost-curbing measures, strategic initiatives and a solid guidance are likely to bump up its shares.
UHS vs. ACHC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UHS vs. ACHC: Which Stock Is the Better Value Option?
Here's Why You Should Buy Acadia Healthcare (ACHC) Stock Now
by Zacks Equity Research
Acadia Healthcare (ACHC) continues to gain from top-line growth, solid demand for behavioral health services, several growth-related initiatives and reducing debt levels.
Acadia Healthcare (ACHC) Starts Building New Behavioral Facility
by Zacks Equity Research
Acadia Healthcare (ACHC) opens a new behavioral facility to tap the growing market of mental illness.
Community Health (CYH) Up 136.3% in a Year: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) cost-cutting measures and strategic initiatives are likely to drive its shares higher.
UHS vs. ACHC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UHS vs. ACHC: Which Stock Is the Better Value Option?
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Backed by its strategic measures, solid segmental contributions and a strong solvency level, Universal Health (UHS) holds potential to reap benefits for investors.
Tenet Healthcare (THC) Expands Its Relationship With Cigna
by Zacks Equity Research
Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.
Cigna (CI) Extends Tie-Up to Offer Better Care in Connecticut
by Zacks Equity Research
Cigna (CI) extends relationship with Hartford HealthCare to jointly offer enhanced healthcare services and thus, better health outcomes in Connecticut.
Acadia Healthcare (ACHC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Encompass Health (EHC) Opens Hospital, Boosts Florida Footprint
by Zacks Equity Research
Encompass Health (EHC) opens an inpatient rehabilitation hospital in Pensacola, FL aimed at providing improved health outcomes across the state.
Why Is Acadia Healthcare (ACHC) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare
Tenet Healthcare (THC) Hits 52 Week High: More Upside Left?
by Zacks Equity Research
Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it aid its upsurge.